col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


147 Results       Page 1

 [1] 
Ovid: Journal of Hypertension
  original article Date Title Authors   All Authors
1 [GO] 2022―Sep―02 Coronavirus disease 2019 infection and subsequent cardiovascular complications Tomoyuki Kawada
2 [GO] 2022―Aug―11 The effects of hypertension on the prognosis of coronavirus disease 2019: a systematic review and meta-analysis on the interactions with age and antihypertensive treatment Alimamy Umaru Kabia, Ping Li, Zhichao Jin, Xiaojie Tan, Yilong Liu, Yuqi Feng, et al. (+4)
3 [GO] 2022―Aug―09 Stay alert about coagulation parameters - implications of thrombosis treatment in COVID-19: Erratum
4 [GO] 2022―Aug―09 Preeclampsia and severe acute respiratory syndrome coronavirus 2 infection: a systematic review Giovanni Tossetta, Sonia Fantone, Nicola delli Muti, Giancarlo Balercia, Andrea Ciavattini, Stefano Raffaele Giannubilo, Daniela Marzioni
5 [GO] 2022―Jun―28 Severe COVID-19 infection and cardiovascular disease - a long-term relationship or short myocardial affair? Manish Motwani
6 [GO] 2022―Jun―14 ENDOTHELIAL COMPLICATIONS IN HYPERTENSIVE PATIENTS WITH OBESITY OR NORMAL BODY WEIGHT AFTER COVID-19 Izolda Kokaeva, Yulia Zhernakova, Natalia Blinova, Eugenia Elfimova, Olga Pogorelova, Maria Tripoten, Irina Chazova
7 [GO] 2022―Jun―14 ASSOCIATION OF IN-PATIENT OUTCOMES AND RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR USE AMONG HYPERTENSIVE PATIENTS WITH CORONAVIRUS DISEASE 2019 (COVID-19) Ma. Cecilia Lozada, Henry Medina, Ma Sergia Fatima Sucaldito, Lourdes Ella Santos, Deborah Ignacia David-Ona, Raymond Oliva
8 [GO] 2022―Jun―14 THE PROGNOSTIC VALUE OF THE BIOLOGICAL PROFILE OF INFLAMMATION AND COAGULATION AT HYPERTENSIVE PATIENTS AFTER COVID-19 Adrian Gavrila
9 [GO] 2022―Jun―14 THE FEATURE OF ATRIAL FIBRILLATION OCCURRENCE AND PROGRESSION IN PATIENTS WITH ARTERIAL HYPERTENSION, WHO HAVE UNDERGONE COVID-19 Lusine Hazarapetyan, Svetlana Grigoryan, Parunak Zeveian
10 [GO] 2022―Jun―14 ARTERIAL HYPERTENSION FOLLOWING COVID-19 Didi Delalic, Juraj Jug, Vamsi Varahabhatla, Ingrid Prkacin
11 [GO] 2022―Jun―14 OPTIMIZATION OF BLOOD PRESSURE CONTROL AND ANGIOPROTECTION WITH FIXED COMBINATION OF LISINOPRIL + AMLODIPINE + ROSUVASTATIN IN PATIENTS AFTER A COVID-19 Sergey Nedogoda, Alla Ledyaeva, Elena Chumachek, Vera Tsoma, Alla Salasyuk, Viktoriya Lutova, et al. (+5)
12 [GO] 2022―Jun―14 IMPAIRED BETA-2ADRENERGIC ENDOTHELIUM-DEPENDENT VASODILATION IS REVERSED BY PHOSPHODIESTERASE INHIBITION IN PATIENTS PREVIOUSLY HOSPITALIZED WITH COVID-19 Luca Faconti, Bushra Farukh, Ryan McNally, Sally Brett, Philip Chowienczyk
13 [GO] 2022―Jun―14 DYNAMICS OF ECHOCARDIOGRAPHY CHARACTERISTICS OF THE MYOCARDIUM IN PATIENTS WITH CONFIRMED DIAGNOSIS OF COVID-19 Larisa Minushkina, Tatyana Davydova, Natalya Chuprik, Anna Snigirova
14 [GO] 2022―Jun―14 STAY ALERT ABOUT COAGULATION PARAMETERS - IMPLICATIONS OF THROMBOSIS TREATMENT IN COVID-19 Piotr Sielatycki, Edyta Zbroch, Martyna Markowska, Aleksandra Zalewska, Aleksandra Bowtruczuk, Jedrzej Warpecowski, Malgorzata Gryciuk
15 [GO] 2022―Jun―14 ELEVATED RESTING HEART RATE AS INDEPENDENT IN-HOSPITAL PROGNOSTIC MARKER IN COVID-19 Gino Serravalle, Jennifer Vanoli, Raffaella Dell’Oro, Giacomo Marro, Rita Facchetti, Fosca Quarti-Trevano, et al. (+2)
16 [GO] 2022―Jun―14 COLCHICINE FOR THE PREVENTION OF COVID-19 “HARD” OUTCOMES: ALL THAT GLITTERS IS NOT GOLD. AN UPDATED ANALYSIS OF RANDOMIZED CONTROLLED TRIALS Dimitrios Patoulias, Alexandra Katsimardou, Konstantinos Imprialos, Konstantinos Stavropoulos, Christodoulos Papadopoulos, Michael Doumas
17 [GO] 2022―Jun―14 TREATMENT WITH BLOCKERS OF THE RENIN-ANGIOTENSIN SYSTEM DOES NOT AFFECT RENAL FUNCTION IN PATIENTS WITH SEVERE COVID-19 ADMITTED TO INTENSIVE CARE UNIT Francesco Salvo, Elisa Gallo, Anna Botto, Alessio Risoli, Paolo Parola, Rita Tenio, et al. (+4)
18 [GO] 2022―Jun―14 COVID-19 AND CARDIOVASCULAR SYSTEM: NOT ONLY HEART BUT ALSO VASCULAR. THE EFFECTS OF THE INFECTION ON ARTERIAL STIFFNESS Alessandro Maloberti, Elena Gualini, Sara Scarpellini, Michela Algeri, Marco Biolcati, Enzo Grasso, et al. (+4)
19 [GO] 2022―Jun―14 COVID-19 AND NEW ONSET HYPERTENSION Evgeniya Shalaeva, Maksuda Shamsutdinova, Alisher Shadmanov, Shukhrat Boymuradov, Feruza Azizova, Dilshod Allaberganov, et al. (+2)
20 [GO] 2022―Jun―14 COVID-19 ASSOCIATED REDUCTION IN HYPERTENSION-RELATED DIAGNOSTIC AND THERAPEUTIC PROCEDURES IN EXCELLENCE CENTERS OF THE EUROPEAN SOCIETY OF HYPERTENSION Thomas Weber, Reinhold Kreutz, Andrzej Januszewicz, Christopher Mayer, Konstantinos Tsioufis, György Abraham, et al. (+5)
21 [GO] 2022―Jun―14 GLOMERULAR HYPERFILTRATION MAY CONTRIBUTE TO RENAL TROPISM AND KIDNEY INJURY IN COVID-19 BY UPREGULATING ACE2 IN HUMAN PODOCYTES Juliane Bolbrinker, Eva Mangelsen, Aikaterini Kourpa, Kaiser Debora, Panakova Daniela, Kreutz Reinhold
22 [GO] 2022―Jun―14 THE COURSE OF ATRIAL FIBRILLATION AFTER A PREVIOUS INFECTION WITH COVID-19 DEPENDING ON THE PRESENCE OF ARTERIAL HYPERTENSION Oleg Sychov, Oksana Stasyshena, Olena Ilchyshyna, Yu Zinchenko, Taisiya Getman, Olena Romanova, Olga Sribna
23 [GO] 2022―Jun―14 COVID-19 IMPACT ON THE PREVALENCE OF SUBCLINICAL HYPERTENSION AMONG PRACTICALLY HEALTHY MEDICAL STUDENTS Yulia Yufereva, Oleg Shevchenko, Leonid Ginzburg, Artem Zakirzyanov, Alex Shevchenko
24 [GO] 2022―Jun―14 DETERMINANTS OF OUTCOME OF MODERATE TO SEVERE COVID-19 IN A HOSPITAL SETTING: A COMPARISON BETWEEN FIRST AND SECOND/THIRD WAVE IN LOMBARDY Gianluca Boari, Francesca Leidi, Beatrice Accordini, Federico Napoli, Chiara Ghidelli, Giulia Archenti, et al. (+18)
25 [GO] 2022―Jun―14 COVID-19 INFECTION AND ARTERIAL HYPERTENSION - A RECIPROCAL INTERACTION? Filipa Ferreira Rodrigues, Juliana Sá
26 [GO] 2022―Jun―14 COVID-19 IS ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION: A META-ANALYSIS OF OBSERVATIONAL STUDIES Dimitrios Patoulias, Alexandra Katsimardou, Konstantinos Stavropoulos, Konstantinos Imprialos, Asterios Aidinis, Asimina Sviggou, et al. (+4)
27 [GO] 2022―Jun―14 ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS AS A RISK FACTOR FOR PATIENTS HOSPITALIZED WITH COVID-19. IS THAT TRUE? Paula Luque, Luis Castilla-Guerra, Maria Ferrary, Nieves Sanchez, Maria Alegre, Eduardo Carmona, Miguel Angel Rico
28 [GO] 2022―Jun―14 SELF-REPORTED CHANGE IN (UN)HEALTHY BEHAVIOURS OF PATIENTS WITH CARDIOVASCULAR DISEASES DURING THE SECOND COVID-19 LOCKDOWN IN NORTHERN GREECE: FOCUS ON DIABETES Antonios Ioannidis, Apostolos Pechlevanis, Afroditi Fragkiskou, Filio Asmani
29 [GO] 2022―Jun―14 PHYSICAL ACTIVITY AND LIFESTYLE CHANGES IN ITALY DURING THE COVID-19 LOCKDOWN: GENDER DIFFERENCES Alessio Pellegrino, Martina Rosselli, Melissa Orlandi, Maria Boddi, Laura Stefani, Loira Toncelli, Pietro Amedeo Modesti
30 [GO] 2022―Jun―14 ASSESSMENT OF ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN A POPULATION OF ARGENTINA DURING THE COVID-19 PANDEMIC Nicolas Renna, Emiliano Diez, Sergio Vissani, Beder Farez, Viviana Sorasio, Belen Camaño, et al. (+3)
31 [GO] 2022―Jun―14 LEVERAGING TECHNOLOGY TO SUPPORT PEOPLE LIVING WITH HYPERTENSION AND DIABETES DURING THE COVID-19 PANDEMIC Aima Adebo Uagboe, Ayoposi Ogboye, Maria Moosa Munee, Km Jawadur Rahman, Jonas Kofi Akpakli, Nneka Mobisson
32 [GO] 2022―Jun―14 BLOOD PRESSURE CONTROL RATES PREVIOUS AND DURING THE COVID-19 PANDEMIC IN BRAZIL Lucas Lima, Priscila Vitorino, Suelen Silva, Ana Sousa, Weimar Barroso
33 [GO] 2022―Jun―14 IMPACT OF THE COVID-19 PANDEMIC ON THE INITIATION OF ANTIHYPERTENSIVE DRUG THERAPY IN FRANCE Valérie Olié, Clemence Grave, Philippe Tuppin, Thomas Lesuffleur, Charles Guenancia, Jacques Blacher, Amélie Gabet
34 [GO] 2022―Jun―14 EFFECT OF THE COVID-19 PANDEMIC ON THE NYCHTHEMERAL BLOOD PRESSURE PROFILE Daryl Tcheutchoua Nzokou, Phillipe van de Borne, Martin Chaumont
35 [GO] 2022―Jun―14 LATVIA’S DOCTORS EXPERIENCE ON PROVIDING REMOTE CONSULTATIONS DURING COVID-19 PANDEMICS Aleksandra Jeniceka, Dzintra Homka, Ieva Bikava, Sevinç Elif Sen, Emma Sokolova
36 [GO] 2022―Jun―14 CONTINUOUS REMOTE PATIENT MONITORING SHOWS EARLY CARDIOVASCULAR CHANGES IN COVID-19 PATIENTS Arik Eisenkraft
37 [GO] 2022―Jun―14 CONTINUES REMOTE CARDIAC MONITORING IN CRITICALLY ILL COVID-19 PATIENTS (C3 STUDY) Avinash Hanbe Rajanna, Jeetendra Kumar
38 [GO] 2022―Jun―14 IMPACT OF ARTERIAL HYPERTENSION AND ANTIHYPERTENSIVE PHARMACOTHERAPY ON IN-HOSPITAL MORTALITY IN COVID-19 PATIENTS: THE CRACOV-HHS STUDY Wiktoria Wojciechowska, Michal Terlecki, Marek Klocek, Andrzej Januszewicz, Tomasz Grodzicki, Reinhold Kreutz, Marek Rajzer
39 [GO] 2022―Jun―14 AORTIC STIFFNESS AND INDEXES OF DISEASE SEVERITY IN SUBJECTS WITH PREVIOUS COVID-19 PNEUMONIA: A FOLLOW-UP STUDY Valeria Baiano, Cristiana Catena, Luca Bulfone, Laura Scandolin, Antonio Vacca, Gabriele Brosolo, et al. (+6)
40 [GO] 2022―Jun―14 COVID-19 RELATED CHANGE IN DAILY LIFE OF HYPERTENSIVE PATIENTS MAY AFFECT HYPERTENSION MANAGEMENT Vasiliki Tsoutsouli, Zacharo Sachla, Kyprianos Efstathiou, Dimos Foutsitsakis, Alexander James Damianos, Konstantinos Gkogkos
41 [GO] 2022―Jun―14 SHORT-TERM BLOOD PRESSURE ALTERATIONS AFTER COVID-19 VACCINATION Elias Sanidas, Dimitrios Papadopoulos, Theoharis Anastasiou, Maria Velliou, Eftixia Michalaki, Anastasia Fotsali, et al. (+3)
42 [GO] 2022―Jun―14 ACUTE MYOCARDITIS FOLLOWING COVID-19 VACCINATION: A PECULIAR CASE SERIES Sara Corradetti, Matteo Sclafani, Raffaella Mistrulli, Giovanna Gallo, Erika Pagannone, Marco Di Girolamo, et al. (+3)
43 [GO] 2022―Jun―14 THE EFFECT OF COVID-19 VACCINE ON ARTERIAL FUNCTION Dimitrios Terentes-Printzios, Vasiliki Gardikioti, Eirini Solomou, Eleni Emmanouil, Ioanna Gourgouli, Panagiotis Xydis, et al. (+8)
44 [GO] 2022―Jun―14 FACTORS THAT INFLUENCE THE SURVIVAL RATE IN PATIENTS WITH COVID-19 WITH A PREVIOUS DIAGNOSIS OF HYPERTENSION AND/OR DIABETES: A SYSTEMATIC REVIEW Leslie Montealegre, Eulalia Amador, Tammy Pulido, Roberto Rebolledo, Lisbeth Olvera, Brenda Pacheco
45 [GO] 2022―Jun―14 SELF-ASSESSMENT OF VITAL SIGNS AND SYMPTOMS OF COVID-19: BLOOD PRESSURE MEASUREMENTS RESULTS FROM THE HYTECC STUDY André Michaud, Lyne Cloutier, Alain Vadeboncoeur, Rémi Goupil
46 [GO] 2022―Jun―14 EFFECT OF HYPERTENSION AND RAS INHIBITORS TO ADULT PATIENTS (OVER 18 YEARS OLD) WITH SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV2) INFECTION WHO WERE ADMITTED TO HOSPital Imola Fejes, Richárd Róka, György Ábrahám, Tamás Várkonyi, Csaba Lengyel, Péter Légrády
47 [GO] 2022―Jun―14 CORONAVIRUS DISEASE-2019 IS ASSOCIATED WITH ARTERIAL STIFFNESS IMPAIRMENT: A META-ANALYSIS OF OBSERVATIONAL STUDIES Dimitrios Patoulias, Alexandra Katsimardou, Konstantinos Imprialos, Konstantinos Stavropoulos, Asimina Sviggou, Asterios Aidinis, et al. (+4)
48 [GO] 2022―Jun―14 FEATURES OF THE PARAMETERS OF RED BLOOD CELLS AND HEMOSTASIS IN PATIENTS WITH STROKES ASSOCIATED WITH CORONAVIRUS INFECTION Margarita Vitali Kruchinina, Andrey Alexandro Gromov, Vladimir Mikhail Generalov, Anna Vladimirovn Rabko
49 [GO] 2022―Jun―14 THE ROLE OF BLOOD PRESSURE LEVEL IN THE DEVELOPMENT OF ATRIAL FIBRILLATION AFTER CORONAVIRUS INFECTION Oksana Stasushena
50 [GO] 2022―Jun―14 EFFECT OF CORONAVIRUS INFECTION ON PATIENTS WITH CONTROLLED AND UNCONTROLLED ARTERIAL HYPERTENSION Anastasiya Denisova, Olga Sivakova, Tatyana Solntseva, Irina Chazova
51 [GO] 2022―Jun―14 IMMUNE DYSREGULATION INDUCED BY SPIKE PROTEIN 1 OF SARS-COV-2 INCREASES ENDOTHELIAL CELL DYSFUNCTION VIA TYPE I AND TYPE III INTERFERON ACTIVATION PATHWAYS Francisco J. Rios, Augusto C. Montezano, Livia L. Camargo, Rheure A. Lopes, Ana B. Garcia-Redondo, Eliju Aranday-Cortes, et al. (+3)
52 [GO] 2022―Jun―14 ATRIAL FIBRILLATION INCIDENCE IN SARS-COV-2 INFECTED PATIENTS: PREDICTORS AND RELATIONSHIP WITH IN-HOSPITAL MORTALITY Alessandro Maloberti, Cristina Giannattasio, Paola Rebora, Giuseppe Occhino, Nicola Ughi, Jacopo Rizzo, et al. (+11)
53 [GO] 2022―Jun―14 IMPACT OF HYPERTENSION AS AN ADDITIONAL RISK FACTOR IN CARDIORESPIRATORY STATUS OF POST SARS-COV-2 INFECTED SUBJECTS Maria Kariori, Christos Fragoulis, Dimitrios Polyzos, Ioannis Leontsinis, Kalliopi Grigoriou, Sotirios Drogkaris, et al. (+9)
54 [GO] 2022―Jun―14 CLINICAL AND MORPHOLOGICAL FEATURES OF KIDNEY DAMAGE IN PATIENTS WITH ARTERIAL HYPERTENSION DIED OF SARS-COV-2 INFECTION Tatiana Makeeva, Elizaveta Zbyshevskaya, Fatima Bitakova, Vadim Erinchek, Sergey Saiganov, Oksana Zaytseva, et al. (+4)
55 [GO] 2022―Jun―14 IMPAIRED ACE2 GLYCOSYLATION AND PROTEASE ACTIVITY LOWERS SUSCEPTIBILITY TO SARS-COV-2 INFECTION IN GITELMAN/BARTTER SYNDROMES Giovanni Bertoldi, Verdiana Ravarotto, Luca Sgarabotto, Laura Gobbi, Lucia Federica Stefanelli, Lorenzo A. Calò
56 [GO] 2022―Jun―14 PARTICULARITIES OF HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME, ADMITTED FOR SARS-COV-2 INFECTION TO A CLINICAL EMERGENCY HOSPITAL Raluca Stirban, Cristiana Grigore, Doina Dragoi, Beatrice Balaceanu, Cristian-Dorin Gurau, Cornelia Voiculet, et al. (+7)
57 [GO] 2022―Jun―14 MICROCIRCULATION AND SARS-COV-2 INFECTION: A FOLLOW UP STUDY Paolo Malerba, Claudia Agabiti Rosei, Giulia Chiarini, Matteo Nardin, Alina Petelca, Andrea Gaggero, et al. (+11)
58 [GO] 2022―Jun―14 IT IS SOMETHING MAKING THE DIFFERENCE BETWEEN HYPERTENSIVE PATIENTS WITH METABOLIC SYNDROME VERSUS HYPERTENSIVE PATIENTS WITHOUT METABOLIC SYNDROME IN SARS-COV-2 INFECTION? Raluca Stirban, Doina Dragoi, Cristiana Grigore, Beatrice Balaceanu, Cristian-Dorin Gurau, Cornelia Voiculet, et al. (+7)
59 [GO] 2022―Jun―14 COMPARISON BETWEEN FIRST AND SECOND/THIRD WAVE OF SARS-COV-2 MODERATE TO SEVERE INFECTION IN ELDERLY PATIENTS IN AN NORTH ITALIAN HOSPITAL SETTING Gianluca Boari, Francesca Leidi, Beatrice Accordini, Benedetta Mangili, Chiara Ghidelli, Giulia Archenti, et al. (+19)
60 [GO] 2022―Jun―14 CARDIOPULMONARY EXERCISE TEST AND ECHOCARDIOGAPHIC FINDINGS IN HOSPITALISED POST SARS-COV-2 PATIENTS: THE EFFECT OF ARTERIAL HYPERTENSION Maria Kariori, Christos Fragoulis, Christina Chrysochoou, Ioannis Leontsinis, Emmanoyil Mantzouranis, Panagiotis Iliakis, et al. (+6)
61 [GO] 2022―Jun―14 NEW ONSET OF HYPERTENSION IN PATIENTS ADMITTED FOR INFECTION WITH SARS-COV-2 VIRUS Raluca Stirban, Cristiana Grigore, Doina Dragoi, Beatrice Balaceanu, Cristian-Dorin Gurau, Cornelia Voiculet, et al. (+7)
62 [GO] 2022―Jun―14 THE IMPACT OF HYPERTENSION AND ANTIHIPERTENSIVE TREATMENTS ON PATIENTS WITH SARS-COV-2: A RETROSPECTIVE-COHORT STUDY Paula Luque, Luis Castilla-Guerra, Nieves Sanchez, Maria Delgado, Maria Alegre, Eduardo Carmona, Miguel Angel Rico
63 [GO] 2022―Jun―14 IS HOME BLOOD PRESSURE SELF MONITORING HERE TO STAY? AN EVALUATION OF PATIENT SATISFACTION WITH HOME BLOOD PRESSURE MONITORING IN A RURAL POPULATION DURING THE COVID PANDEMIC Anjali Patel, Reshma Rasheed, Ahmad Zarif, Azad Mahmod, Hajira Bibi, Imad Nazir
64 [GO] 2022―Jun―14 MUSIC THERAPY WITH HYPERTENSIVE PATIENTS DURING THE PANDEMIC PERIOD - ONLINE MEETINGS AS PART OF MULTIPROFESSIONAL TREATMENT Claudia Zanini, Diana Teixeira, Dalma Pereira, Ana Luiza L. Sousa, Weimar K.S.B. Souza
65 [GO] 2022―Jun―14 TELEMEDICINE AND HEALTH POLICY CHANGES IN RESPONSE TO RESTRICTIONS RELATED TO COVID-19 PANDEMICS IN LATVIA Sevinc Elif Sen, Emma Sokolova, Aleksandra Jeniceka, Ieva Bikava
66 [GO] 2022―May―17 42 BLOOD PRESSURE DURING INFECTION AND SERUM CREATININE CONCENTRATIONS PREDICT SEVERE DISEASE IN COVID-19 I. Gde Raka Widiana, I. Made Bagiada, Wira Mahandita
67 [GO] 2022―May―17 7 IMPACT OF DAY-TO-DAY BLOOD PRESSURE VARIABILITY TO IN-HOSPITAL MORTALITY IN PATIENTS WITH COVID-19 AND EFFICACY OF ANTIHYPERTENSIVE AGENTS G.N.P. Jagannatha, I.W.A.S. Pradnyana, S. Kamardi, A.A.A.D.A. Yasmin
68 [GO] 2022―May―17 13 THE ROLE OF HYPERTENSION AS A RISK FACTOR FOR ACUTE KIDNEY INJURY IN COVID-19 AT RSUP HAJI ADAM MALIK MEDAN: A CROSS-SECTIONAL STUDY IN 2020 Mutia Chairani, Annisa Nidya Rahmatika Sitepu, Riri Andri Muzasti
69 [GO] 2022―May―17 11 NEWLY-DIAGNOSED HYPERTENSION DURING ADMISSION FOR COVID-19 CARE AND ITS SUBSEQUENT EFFECT ON OUTCOME OF TREATMENT: A PROSPECTIVE COHORT STUDY M.A. Sholehuddin, M.A.R. Firmansya, N.H.R. Ilahi, K. Wahyuni, A. Lutfiyah, W.K. Ilahi
70 [GO] 2022―May―17 25 HYPERTENSION AND MORTALITY PREDICTOR WITHIN 10 DAYS AMONG END-STAGE RENAL DISEASE WITH COVID-19 INFECTION Langgeng Perdhana, Shofa Chasani, Muchlis Achsan Udji Sofro
71 [GO] 2022―May―17 Virtual management of hypertension: lessons from the COVID-19 pandemic-International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension Nadia A. Khan, George S. Stergiou, Stefano Omboni, Kazuomi Kario, Nicolas Renna, Niamh Chapman, et al. (+10)
72 [GO] 2022―May―17 16 OBSERVING PATIENTS' NON-ADHERENCE TO HYPERTENSION CONTROL DURING COVID-19 PANDEMIC: A QUALITATIVE STUDY IN THE PUBLIC HEALTH CENTER SETTING I Putu Hendri Aryadi, Made Martha Pradnyana, Made Ayu Hapsari Dwi Ambarini, I Gusti Ayu Nila Kusumawati.
73 [GO] 2022―May―17 43 CHARACTERISTICS AND MORTALITY IN HYPERTENSIVE COVID-19 PATIENTS AT A DISTRICT HOSPITAL IN NORTH JAKARTA: A CROSS-SECTIONAL STUDY Tantika Andina, Marcel H.R. Sibarani
74 [GO] 2022―May―17 39 CHARACTERISTICS AND MORTALITY IN HYPERTENSIVE COVID-19 PATIENTS AT A DISTRICT HOSPITAL IN NORTH JAKARTA: A CROSS-SECTIONAL STUDY Tantika Andina, Marcel H.R. Sibarani
75 [GO] 2022―May―17 46 ANGIOTENSIN-CONVERTING ENZYME INHIBITORS/ANGIOTENSIN RECEPTOR BLOCKER IMPROVES CLINICAL OUTCOMES IN COVID-19 PATIENTS: A META-ANALYSIS Bayushi Eka Putra, Bambang Widyantoro, Rido Maulana, Agnes Dinar Putrinarita, Bhayu Hanggadhi Nugroho, Anwar Santoso
76 [GO] 2022―Feb―28 Cardiovascular outcome 6 months after severe coronavirus disease 2019 infection Anne G. Raafs, Mohammed A. Ghossein, Yentl Brandt, Michiel T.H.M. Henkens, M. Eline Kooi, Kevin Vernooy, et al. (+9)
77 [GO] 2022―Feb―15 The counter-regulatory arm of the renin-angiotensin system and COVID-19 Lucia Federica Stefanelli, Verdiana Ravarotto, Giovanni Bertoldi, Lorenzo A. Calò
78 [GO] 2021―Dec―10 Antecedent use of renin-angiotensin system inhibitors is associated with reduced mortality in elderly hypertensive Covid-19 patients Mauro Gori, Carlo Berzuini, Emilia D’Elia, Arianna Ghirardi, Luisa Bernardinelli, Antonello Gavazzi, et al. (+15)
79 [GO] 2021―Dec―04 A low aldosterone/renin ratio and high soluble ACE2 associate with COVID-19 severity Sakir Akin, Paula Schriek, Cees van Nieuwkoop, Rugina I. Neuman, Iwan Meynaar, Erik J. van Helden, et al. (+17)
80 [GO] 2021―Jul―02 The interaction of the severe acute respiratory syndrome coronavirus 2 spike protein with drug-inhibited angiotensin converting enzyme 2 studied by molecular dynamics simulation Babak Nami, Avrin Ghanaeian, Kasra Ghanaeian, Rozhin Houri, Negin Nami, Armin Ghasemi-Dizgah, Oana Caluseriu
81 [GO] 2021―Jul―02 Impact of renin-angiotensin-aldosterone system inhibitor continuation on outcomes for patients with severe coronavirus disease 2019 manifestations Alberto Palazzuoli, Kristen M. Tecson, Peter A. McCullough
82 [GO] 2021―Jul―02 SARS-CoV-2 infection and ACE2 inhibition Fabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
83 [GO] 2021―Jun―02 Cardiovascular system in the sars-CoV-2: impact of therapies Josep Redon
84 [GO] 2021―May―12 33. CHARACTERISTICS AND COMORBIDITIES OF HYPERTENSIVE PATIENTS IN SANGLAH GENERAL HOSPITAL DURING COVID-19 PANDEMIC I Wayan Agus Surya Pradnyana, Gusti Ngurah Prana Jagannatha, Stanly Kamardi, AA Ayu Dwi Adelia Yasmin
85 [GO] 2021―May―12 34. BLOOD PRESSURE CONTROL AMONG HYPERTENSIVE PATIENTS IN SANGLAH GENERAL HOSPITAL DURING COVID-19 PANDEMIC Stanly Kamardi, Gusti Ngurah Prana Jagannatha, I Wayan Agus Surya Pradnyana, AA Ayu Dwi Adelia Yasmin
86 [GO] 2021―May―12 54. COMPARATION OF D-DIMER LEVELS IN HYPERTENSIVE AND NON-HYPERTENSIVE ADULT COVID-19 PATIENTS Tantika Andina, Daulat JPM Tampubolon
87 [GO] 2021―May―12 77. ASSOCIATION OF D-DIMER AND FIBRINOGEN LEVEL WITH MORTALITY OF HYPERTENSIVE COVID-19 PATIENTS V. Damay, C. Sugeng, O. Umboh, E. Moeis
88 [GO] 2021―May―12 70. ASSOCIATION BETWEEN HYPERTENSION AND IN-HOSPITAL MORTALITY IN COVID-19 PATIENTS Iswandy Janetputra Turu’ Allo, Badai Bhatara Tiksnadi, Pranata Priyo Prakoso, Hana Hadianty Najiyah, Mira Rahmawati, Mira Hasmirani, et al. (+3)
89 [GO] 2021―May―12 25. PRO-INFLAMMATORY MARKERS IN COVID-19 PATIENTS WITH HYPERTENSION Rizky Andhika, Rudi Supriyadi, Bachti Alisjahbana
90 [GO] 2021―May―12 68. ASSOCIATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BLOCKER DRUGS AND OUTCOMES IN COVID-19 PATIENTS WITH HYPERTENSION Mefri Yanni
91 [GO] 2021―May―12 21. THE PROFILE OF COVID-19 PATIENTS WITH HYPERTENSION AT SILOAM DHIRGA SURYA HOSPITAL FROM MAY TO NOVEMBER 2020 Epifanus Arie Tanoto, Sri Wahyuni, Abdul Halim Raynaldo
92 [GO] 2021―May―12 44. RELATIONSHIP BETWEEN HYPERTENSION AND HYPONATREMIA IN CORONAVIRUS DISEASE PATIENTS: A CROSS-SECTIONAL STUDY Ayu Pramitha Wulandari, Dhani Tri Wahyu Nugroho
93 [GO] 2021―Apr―17 Relationship between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and COVID-19 incidence or severe disease Gary Tse, Jiandong Zhou, Sharen Lee, Wing Tak Wong, Xintao Li, Tong Liu, et al. (+6)
94 [GO] 2021―Apr―09 IN-HOSPITAL DIURETIC USE IS ASSOCIATED WITH WORSE OUTCOME IN PATIENTS WITH COVID-19 M. Pengo, G Stefanini, C Pivato, D Soranna, G Zambra, A Zambon, et al. (+4)
95 [GO] 2021―Apr―09 ASSOCIATION OF HYPERTENSION WITH ALL-CAUSE MORTALITY AMONG HOSPITALIZED PATIENTS WITH COVID-19 Enrique Rodilla, Alberto Saura, Iratxe Jiménez, Andrea Mendizábal, Araceli Pineda-Cantedo, Elizabeth Lorenzo-Hernández, et al. (+19)
96 [GO] 2021―Apr―09 PLASMA ACE2 ACTIVITY IS INCREASED IN PATIENTS RECOVERED FROM SARS-COV-2 INFECTION: IMPLICATIONS FOR THE PROLONGED CONSEQUENCES OF COVID-19 Sheila Patel, Jennifer Juno, Wen Shi Lee, Kathleen Wragg, P. Mark Hogarth, Stephen Kent, Louise Burrell
97 [GO] 2021―Apr―09 HYPERTENSION PHENOTYPES, TARGET ORGAN DAMAGE AND STIFF ARTERIES AND SEVERITY OF COVID-19 Azra Mahmud, Nawaf Abdulaziz Alhabdan, Mohammad Hamad Alkhdiri, Ruba Alahaideb, Rajkumar Rajendrum
98 [GO] 2021―Apr―09 HYPERTENSION IS A RISK FACTOR FOR ACUTE KIDNEY INJURY AND A PREDICTOR OF MORTALITY IN HOSPITALIZED PATIENTS WITH COVID-19 Yulia Khruleva, Tapiwa Mubayazvamba, Elena Troitskaya, Marina Efremovtseva, Zhanna Kobalava
99 [GO] 2021―Apr―09 COMORBIDITIES FACTORS AND HYPERTENSION IN RELATION TO COVID-19 Jong Hoon Koh, Enjin Shim, Minjeong Kang, Inkyeong Hwang
100 [GO] 2021―Apr―09 THE PREVALENCE OF ARTERIAL HYPERTENSION AMONG PATIENTS HOSPITALIZED WITH COVID-19 Kseniia Eruslanova, Anna Akapyan, Irina Malaya, Irina Strojesko, Nikolay Leonov, Julia Kotovskaya, et al. (+2)
101 [GO] 2021―Apr―09 EVIDENCE OF A BLOOD PRESSURE REDUCTION DURING THE COVID-19 ASSOCIATED LOCKDOWN: A PLAUSIBLE EXPLANATION FOR THE OBSERVED DECLINES IN ACUTE CARDIOVASCULAR DISEASES? Nicolas Girerd, Christophe Meune, Kevin Duarte, Vincent Vercamer, Marilucy Lopez-Sublet, Jean-Jacques Mourad
102 [GO] 2021―Apr―09 LOW MOLECULAR WEIGHT HEPARIN AT HIGH DOSE IMPACTS ON OUTCOME OF COVID-19 HOSPITALIZED PATIENTS, WHILE STANDARD DOSE DOESN’T Silvia Bonetti, Gianluca E.M. Boari, Giulia Chiarini, Cristina Faustini, Gianluca Bianco, Federico Braglia-Orlandini, et al. (+2)
103 [GO] 2021―Apr―09 HYPERTENSIVE PATIENTS ON TREATMENT AND COVID-19 IN FRANCE: FLAHS 2020 SURVEY Olivier Hanon, Atul Pathak, François Silhol, Marie Catherine Wimart, Xavier Girerd
104 [GO] 2021―Apr―09 ROLE OF ACE2 GLYCOSYLATION AND RHO KINASE INHIBITION IN THE INFECTIOUS/THERAPEUTIC PROCESS OF COVID-19. INSIGHTS FROM GITELMAN'S AND BARTTER'S SYNDROMES PATIENTS Giovanni Bertoldi, Lisa Gianesello, Matteo Rigato, Luca Sgarabotto, Lorenzo Calò
105 [GO] 2021―Apr―09 IMPACT OF COVID-19 LOCKDOWN ON VASCULAR STIFFNESS TRAJECTORIES IN FRANCE AND GERMANY Rosa Maria Bruno, Jean-Louis Pepin, Jean-Philippe Empana, Rui-Yi Yang, Vincent Vercamer, Paul Jouhaud, et al. (+2)
106 [GO] 2021―Apr―09 INCREASED CARDIOVASCULAR DEATH RATES IN A COVID-19 LOW PREVALENCE AREA Rita Del Pinto, Giovambattista Desideri, Leondino Mammarella, Stefano Abballe, Sofia Dell’Anna, Sabrina Cicogna, et al. (+3)
107 [GO] 2021―Apr―09 CARDIOVASCULAR COMPLICATIONS FROM COVID-19 MAY BE PREDICTED BY THE INCREASED LEVEL OF C-REACTIVE PROTEIN: A META-ANALYSIS Elona Greca, Muhammad Shah, Krunal Pandav, Dario Dedja, Ilda Hoxhaj
108 [GO] 2021―Apr―09 ADHERENCE TO ANTI-HYPERTENSIVE TREATMENT ON THE COVID-19 PANDEMIC Mayra Cristina Luz Pádua Guimaraes, Juliana Chaves Coelho, Juliano Dos Santos, Camila Braga De Oliveira Higa, Carime Farah Florido, Renata Jae Won Lee, et al. (+3)
109 [GO] 2021―Apr―09 PATIENTS’ PERCEPTIONS ON THE USE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS DURING THE FIRST WAVE OF THE COVID-19 PANDEMIC Antonios Ioannidis, Maria Paraskelidou, Apostolos Pechlevanis, Afroditi Fragkiskou
110 [GO] 2021―Apr―09 THE IMPACT OF COVID-19 PANDEMIC AND LOCKDOWN ON CARDIOMETABOLIC STATUS ON PATIENTS WITHOUT EVIDENCE OF SARS COV-2 INFECTION IN THREE REGIONS OF LATIN AMERICA. A SUB-STUDY OF THE CORCOVID LATAM STUDY Jorge Camilletti, Nicolas Renna, Ricardo Lopez Santi, Juan Erriest, Grecia Perez Siller, Maria Isabel Garcia, et al. (+2)
111 [GO] 2021―Apr―09 THE IMPACT OF COVID-19 PANDEMIC LOCKDOWN ON HYPERTENSIVE INDIVIDUALS WITH COMORBIDITIES OF A LONGITUDINAL COHORT IN INDIA Kaushik Chakraborty, Nilanjana Chakraborty, Ramendra Nath Mitra, Dipra Mitra
112 [GO] 2021―Apr―09 PATIENTS’ PERCEPTIONS ON THE USE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITORS: COMPARISON BETWEEN THE FIRST AND THE SECOND COVID-19 PANDEMIC WAVES Antonios Ioannidis, Apostolos Pechlevanis, Afroditi Fragkiskou, Maria Paraskelidou
113 [GO] 2021―Apr―09 IMPACT OF REDUCTION IN AIRCRAFT NOISE EXPOSURE ON BLOOD PRESSURE AND ARTERIAL STIFFNESS DURING COVID-19 PANDEMIC: CROSS-SECTIONAL AND LONGITUDINAL STUDY Wiktoria Wojciechowska, Andrzej Januszewicz, Tomasz Drozdz, Marta Rojek, Justyna Baczalska, Michal Terlecki, et al. (+8)
114 [GO] 2021―Apr―09 CONDUCTING AN RCT IN THE COVID-19 PANDEMIC: TARGETING VULNERABILITY TO SEASONAL AND ACUTE WEATHER CHANGES TO KEEP AUSTRALIANS WITH CARDIOVASCULAR DISEASE OUT OF HOSPITAL - THE RES Nasreen Moini, Sheila K. Patel, Jay Ramchand, Jody Hook, Christine F. Mcdonald, Simon Stewart, Louise Burrell
115 [GO] 2021―Apr―09 HYPERTENSION ASSOCIATED RISKS DURING THE COVID-19 PANDEMIC: THE PATIENTS’ PERCEPTION Antonios Ioannidis, Afroditi Fragkiskou, Maria Paraskelidou, Apostolos Pechlevanis
116 [GO] 2021―Apr―09 HYPERTENSION AND COVID-19: THE POSSIBLE ROLE OF METALLOPROTEINASE-9 IN COVID-19 PATHOPHYSIOLOGY Carolina Dávila Mesquita, Ariel Emiliano Souza Do Couto, Ligia Borges Campos, Bruno Cesar Petroski Mora, Fabiola Mestriner, Tauana Fernandes Vasconcelo, et al. (+7)
117 [GO] 2021―Apr―09 ASSOCIATION OF ARTERIAL STIFFNESS WITH ALL-CAUSE MORTALITY AMONG HOSPITALIZED COVID-19 PATIENTS Enrique Rodilla, Alberto Belda, Sergio Canales, Maria Quilis, Maria Carmen Saez, Alicia Roldan, et al. (+24)
118 [GO] 2021―Apr―09 ROLE OF HYPERTENSION, CARDIOVASCULAR DISEASE AND CARDIOVASCULAR RISK FACTORS ON OUTCOME IN HOSPITALIZED COVID-19 PATIENTS Giulia Chiarini, Gianluca E.M. Boari, Silvia Bonetti, Federico Braglia Orlandini, Paolo Malerba, Gianluca Bianco, et al. (+2)
119 [GO] 2021―Apr―09 EFFECT OF ONGOING TREATMENT AND DIFFERENT THERAPIES ON PROGNOSIS IN COVID-19 PATIENTS IN AN HOSPITAL SETTING Gianluca Bianco, Gianluca E.M. Boari, Silvia Bonetti, Giulia Chiarini, Federico Braglia Orlandini, Cristina Faustini, et al. (+2)
120 [GO] 2021―Apr―09 GENDER DIFFERENCES IN COVID-19 PATIENTS WITH ARTERIAL HYPERTENSION Tiziana Ciarambino, Filippina Ciaburri, Vera Delli Paoli, Marinella D’avino, Direttivo Fadoi Campania
121 [GO] 2021―Apr―09 ROLE OF HYPERTENSION ON THE SEVERITY AND PROGRESSION OF COVID-19: A RETROSPECTIVE COHORT STUDY IN INDIA Ambily K, Tapas Sadasivan Nair
122 [GO] 2021―Apr―09 RENIN-ANGIOTENSIN SYSTEM INHIBITORS AND COVID-19: A SYSTEMATIC REVIEW AND META-ANALYSIS EVIDENCE FOR SIGNIFICANT GEOGRAPHICAL DISPARITIES Dimitrios Patoulias, Alexandra Katsimardo, Konstantinos Stavropoulo, Konstantinos Imprialos, Maria -Styliani Kalogirou, Michael Doumas
123 [GO] 2021―Apr―09 LEVELS OF IMMUNOGLOBULIN G AND MARKERS OF VASCULAR INFLAMMATORY RESPONSE AS PREDICTORS OF POSSIBLE VASCULAR COMPLICATIONS IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER SARS-COV-2 Tatiana Petelina, Musikhina Natalia, Yaroslavskaya Elena, Gultyaeva Elena, Avdeeva Ksenia, Gorbatenko Elena, et al. (+3)
124 [GO] 2021―Apr―09 SKIN CAPILLARY ALTERATIONS IN PATIENTS WITH ACUTE SARS-COV-2 INFECTION Carolina De Ciuceis, Claudia Agabiti Rosei, Valeria Brami, Claudia Rossini, Andrea Gaggero, Francesca Fama’, et al. (+2)
125 [GO] 2021―Apr―09 IMPACT OF COVID 19 PANDEMIC ON BLOOD PRESSURE OF HEALTHCARE PROFESSIONALS DURING LOCKDOWN - AN INDIAN STUDY Amit Gupta, Anuj Maheshwari, Narsingh Verma, Aravinda Jagadeesha, S.S. Dariya, Amit Sharma, et al. (+9)
126 [GO] 2021―Mar―03 Lessons from COVID-19 mortality data across countries Giovanni Corrao, Federico Rea, Gian Carlo Blangiardo
127 [GO] 2021―Mar―03 Coronavirus disease 2019 and cardiovascular complications Sahrai Saeed, Marijana Tadic, Terje H. Larsen, Guido Grassi, Giuseppe Mancia
128 [GO] 2021―Feb―22 Renin-angiotensin-system inhibitors and all-cause mortality in patients with coronavirus disease 2019 Chirag Bavishi, Paul K. Whelton, Giuseppe Mancia, Giovanni Corrao, Franz H. Messerli
129 [GO] 2020―Dec―31 Lifestyle, psychological, socioeconomic and environmental factors and their impact on hypertension during the coronavirus disease 2019 pandemic Reinhold Kreutz, Piotr Dobrowolski, Aleksander Prejbisz, Engi A.E-H Algharably, Grzegorz Bilo, Felix Creutzig, et al. (+16)
130 [GO] 2020―Dec―04 The corona-virus disease 2019 pandemic compromised routine care for hypertension: a survey conducted among excellence centers of the European Society of Hypertension
131 [GO] 2020―Nov―17 Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during coronavirus disease 2019 Jordana B. Cohen, Lucy D’Agostino-McGowan, Elizabeth T. Jensen, Joseph Rigdon, Andrew M. South
132 [GO] 2020―Nov―04 Renin--angiotensin system blockers and the risk of critical or fatal coronavirus disease 2019 in African Americans Costas Thomopoulos, Helena Michalopoulou
133 [GO] 2020―Oct―06 Association between renin-angiotensin-aldosterone system blockers and outcome in coronavirus disease 2019 Alexandre Lahens, Jimmy Mullaert, Simon Gressens, Nathalie Gault, Martin Flamant, Laurène Deconinck, et al. (+4)
134 [GO] 2020―Aug―05 Immunity, inflammation and the vasculature in the COVID-19 era Aletta E. Schutte, David G. Harrison
135 [GO] 2020―Aug―05 Association between hypertension and pneumonia caused by SARS-CoV-2 in Mexican population Akram Hernández-Vásquez, Rodrigo Vargas-Fernández, Guido Bendezu-Quispe
136 [GO] 2020―Aug―03 Baseline use of angiotensin-converting enzyme inhibitor/AT1 blocker and outcomes in hospitalized coronavirus disease 2019 African-American patients Priyank Shah, Jack Owens, James Franklin, Yash Jani, Ashish Kumar, Rajkumar Doshi
137 [GO] 2020―Jun―05 Are COVID-19 patients with hypertension at higher risk in China? Siqi Wang, Yan Chen, Lu Wang, Huan Liu, Ping Han
138 [GO] 2020―May―30 Food protein-derived antihypertensive peptides in the COVID-19 pandemic Mostafa Goudarzi, Farhad Garavand, Ashkan Madadlou, Vincenzo Fogliano
139 [GO] 2020―May―08 Influence of inhibitors of the renin-angiotensin system on risk of acute respiratory distress syndrome in Danish hospitalized COVID-19 patients Anders Holt, Ikram Mizrak, Morten Lamberts, Per Lav Madsen
140 [GO] 2020―May―06 COVID-19, hypertension and angiotensin receptor-blocking drugs Francisco José Fernández-Fernández
141 [GO] 2020―May―06 Comment on ‘Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?’ Erkan Cüre, Medine Cumhur Cüre
142 [GO] 2020―May―06 Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus Paolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi
143 [GO] 2020―May―06 Hypertension and coronavirus disease 2019 Ari G. Mandler
144 [GO] 2020―May―06 Hypertension and coronavirus disease 2019 mortality Ruben Kevin A. Tapia-Orihuela
145 [GO] 2020―May―06 Could renin-angiotensin-aldosterone system inhibitors be used for hypertensive patients with coronavirus disease 2019? Di Liu, Yun-Zhao Li, Hui Wu
146 [GO] 2020―May―06 Angiotensin-converting enzyme-2 in SARS-CoV-2 infection Jorie Versmissen, Koen Verdonk, Melvin Lafeber, Johannes P.C. van den Akker, Nicole G.M. Hunfeld, Ewout J. Hoorn, A.H. Jan Danser
147 [GO] 2020―Mar―20 Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic? Murray Esler, Danielle Esler
 [1] 

147 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.005 sec